Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-27

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for Amitriptyline Hydrochloride, resulting in changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

SUPPL AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)